Tenkasi 1200 mg powder for concentrate for solution for infusion

Licence status
Authorised: 15/09/2023
Active substances
Oritavancin
Dosage Form
Powder for concentrate for solution for infusion
Licence number
EU/1/15/989/002
Licence holder
Menarini International Operations Luxembourg S.A.

Product documents

Licence information

ATC code
J01XA05 oritavancin
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
15/09/2023